title: [Tulozin in combined treatment of patients with acute urinary retention].
abstract: There is much evidence that tulozin promotes recovery of spontaneous urination, Qmax and is effective in combined treatment of patients with acute retention of urine caused by prostatic adenoma. Tulozin produces positive changes in the lower urinary tract symptoms. Rare occurrence of side effects enables long-term treatment and achievement of good therapeutic response. Tulozin is recommended for patients of younger age, with minimal comorbid pathology, hypotonic with orthostatic reactions, history of side effects in the treatment of other alpha-adrenoblockers, in comorbid hypertention, hypercholesterolemia, retrograde ejaculation, low potention, overactive bladder, prostatitis, after prostatic TUR, transvesical adenomectomy.
authors.forename: V P
authors.initials: VP
authors.lastname: Avdoshin
authors.forename: M I
authors.initials: MI
authors.lastname: Andriukhin
authors.forename: T G
authors.initials: TG
authors.lastname: Mikhaĭlikov
authors.forename: E V
authors.initials: EV
authors.lastname: Ol'shanskaia
authors.forename: A Z
authors.initials: AZ
authors.lastname: Khunov
mesh_terms: D000208:Acute Disease; D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage*; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D008297:Male; D008875:Middle Aged; D011470:Prostatic Hyperplasia / Q000628:therapy; D013449:Sulfonamides / Q000008:administration & dosage*; D000077409:Tamsulosin; D016055:Urinary Retention / Q000628:therapy*
chemical_list: D000317:Adrenergic alpha-Antagonists; D013449:Sulfonamides; D000077409:Tamsulosin